{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:51Z","timestamp":1790375991930,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Peripheral T-cell lymphomas (PTCLs) represent diverse and aggressive malignancies, with few recent therapeutic improvements. Recent high-throughput genomic studies have revealed the complex mutational landscape of these rare diseases. These novel findings provide the grounds to a more comprehensive classification of these diseases, reflected in the 2017 WHO classification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Our review is focused on selected PTCL entities. Angioimmunoblastic T-cell lymphoma and other lymphomas derived from T follicular helper cells feature a rather homogeneous mutational landscape. These neoplasms recapitulate a multistep oncogenic process associating epigenetic deregulation, and second hit mutations affecting the T-cell receptor signaling pathway. This model inferred from comprehensive analyses of patients samples, was confirmed in mouse models. Among ALK-negative anaplastic large-cell lymphomas, translocation-associated subsets are found in both systemic and cutaneous types, and the newly described breast implant-associated type is usually indolent. Extranodal lymphomas of the innate immune system also harbor a combination of mutations affecting different classes of epigenetic modifiers, and mutation-induced activation of the Janus Kinase\/signal transduction and activator of transcription pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Understanding of PTCL pathogenesis has substantially improved, and oncogenic events have been identified. The current challenge is to mount efficient therapeutic strategies targeting these aberrations to improve patients\u2019 outcome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cco.0000000000000474","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T01:10:41Z","timestamp":1532135441000},"page":"277-284","source":"Crossref","is-referenced-by-count":30,"title":["New insights in the pathogenesis of T-cell lymphomas"],"prefix":"10.1097","volume":"30","author":[{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"first","affiliation":[{"name":"Unit\u00e9 H\u00e9mopathie Lympho\u00efde, Hopital Henri Mondor"},{"name":"INSERM U955 and Universit\u00e9 Paris Est Cr\u00e9teil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"INSERM U955 and Universit\u00e9 Paris Est Cr\u00e9teil"},{"name":"D\u00e9partement de Pathologie, Hopital Henri Mondor, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/leu.2014.261","article-title":"Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis","volume":"29","author":"Schatz","year":"2015","journal-title":"Leukemia"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"R7-20230901","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2017.186767","article-title":"RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells","author":"Vallois","year":"2018","journal-title":"Haematologica"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronne","year":"2012","journal-title":"N Engl J Med"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature12750","article-title":"TET enzymes, TDG and the dynamics of DNA demethylation","volume":"502","author":"Kohli","year":"2013","journal-title":"Nature"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrc3895","article-title":"DNMT3A in haematological malignancies","volume":"15","author":"Yang","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","article-title":"The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers","volume":"25","author":"Russler-Germain","year":"2014","journal-title":"Cancer Cell"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3324\/haematol.2017.167973","article-title":"Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas","volume":"103","author":"Lemonnier","year":"2018","journal-title":"Haematologica"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","article-title":"Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities","volume":"3","author":"Cairns","year":"2013","journal-title":"Cancer Discov"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/leu.2017.273","article-title":"Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma","volume":"32","author":"Fujisawa","year":"2018","journal-title":"Leukemia"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3324\/haematol.2014.113696","article-title":"Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas","volume":"100","author":"Manso","year":"2015","journal-title":"Haematologica"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3324\/haematol.2015.139253","article-title":"Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma","volume":"101","author":"Yoo","year":"2016","journal-title":"Haematologica"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.3324\/haematol.2016.147074","article-title":"Comment on: frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al","volume":"101","author":"Gong","year":"2016","journal-title":"Haematologica"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mgg3.121","article-title":"Personalized treatment of Sezary syndrome by targeting a novel CTLA4:CD28 fusion","volume":"3","author":"Sekulic","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.4898","article-title":"TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma","volume":"242","author":"Schwartz","year":"2017","journal-title":"J Pathol"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1073\/pnas.1617929114","article-title":"The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development","volume":"113","author":"Lemonnier","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/leu.2016.29","article-title":"DNMT3A (R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice","volume":"30","author":"Scourzic","year":"2016","journal-title":"Leukemia"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1172\/JCI92026","article-title":"Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis","volume":"127","author":"Zang","year":"2017","journal-title":"J Clin Invest"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17\u200aV induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"key":"R43-20230901","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-11-818617","article-title":"RhoA G17\u200aV is sufficient to induce autoimmunity and promotes T cell lymphomagenesis in mice","author":"Ng","year":"2018","journal-title":"Blood"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"key":"R46-20230901","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R48-20230901","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"R49-20230901","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ijd.13804","article-title":"ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature","volume":"57","author":"Geller","year":"2018","journal-title":"Int J Dermatol"},{"key":"R50-20230901","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"R51-20230901","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/PAP.0000000000000047","article-title":"Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous","volume":"22","author":"Xing","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"R52-20230901","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/his.12529","article-title":"Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features","volume":"66","author":"Onaindia","year":"2015","journal-title":"Histopathology"},{"key":"R53-20230901","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"R54-20230901","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2014-07-588434","article-title":"A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders","volume":"124","author":"Velusamy","year":"2014","journal-title":"Blood"},{"key":"R55-20230901","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"R56-20230901","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jid.2017.10.036","article-title":"Dual role of EZH2 in cutaneous anaplastic large cell lymphoma: promoting tumor cell survival and regulating tumor microenvironment","volume":"138","author":"Yi","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R57-20230901","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"},{"key":"R58-20230901","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"key":"R59-20230901","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"R60-20230901","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cncr.25654","article-title":"Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity","volume":"117","author":"Lechner","year":"2011","journal-title":"Cancer"},{"key":"R61-20230901","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"R62-20230901","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","article-title":"Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma","volume":"101","author":"Blombery","year":"2016","journal-title":"Haematologica"},{"key":"R63-20230901","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjh.14431","article-title":"Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A","volume":"180","author":"Di Napoli","year":"2018","journal-title":"Br J Haematol"},{"key":"R64-20230901","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-018-2352-y","article-title":"Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma","author":"Letourneau","year":"2018","journal-title":"Virchows Arch"},{"key":"R65-20230901","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-110416-120628","article-title":"Disorders of the JAK\/STAT pathway in T cell lymphoma pathogenesis: implications for immunotherapy","volume":"35","author":"Waldmann","year":"2017","journal-title":"Ann Rev Immunol"},{"key":"R66-20230901","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"R67-20230901","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(16)30148-6","article-title":"Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study","volume":"17","author":"Li","year":"2016","journal-title":"Lancet Oncol"},{"key":"R68-20230901","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"R69-20230901","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm.4456","article-title":"Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK\/T cell lymphoma","volume":"24","author":"Wen","year":"2018","journal-title":"Nat Med"},{"key":"R70-20230901","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"R71-20230901","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.12596","article-title":"Recent advances in intestinal lymphomas","volume":"66","author":"Foukas","year":"2015","journal-title":"Histopathology"},{"key":"R72-20230901","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"R73-20230901","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"R74-20230901","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","article-title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"122","author":"Perry","year":"2013","journal-title":"Blood"},{"key":"R75-20230901","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","article-title":"Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update","volume":"35","author":"Matnani","year":"2017","journal-title":"Hematol Oncol"},{"key":"R76-20230901","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","author":"Sharma","year":"2018","journal-title":"Blood"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001622-201809000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:01:38Z","timestamp":1693551698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001622-201809000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000474","relation":{},"ISSN":["1040-8746","1531-703X"],"issn-type":[{"value":"1040-8746","type":"print"},{"value":"1531-703X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}